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Purpose: To investigate whether single nucleotide polymorphisms (SNPs) in the lysyl oxidase-like 1 (LOXL1) gene are
associated with pseudoexfoliation glaucoma (PEG) in the Saudi Arabian population.
Methods: The coding regions of LOXL1 were fully sequenced in 93 clinically diagnosed PEG patients and 101 healthy
controls. Both groups were Saudi Arabs. Previously reported and newly identified SNPs were evaluated for possible
association with PEG and their pathological consequences on the gene were assessed.
Results: The “G” allele frequencies of both rs1048661 and rs3825942 SNPs differed between PEG patients and control
subjects from Saudi Arabia (p=0.0056 and p=0.000005, respectively). This significance remained after applying the
Bonferroni correction. Two non-synonymous novel SNPs in LOXL1 were detected in the PEG patients and not in the
controls. One of these SNPs was in exon 4 (g.25722 C>G; codon change D484E) of LOXL1 and was predicted to be non-
pathological; the other was in exon 6 of LOXL1 (g.28084 T>G; codon change Y559D) and was predicted to be probably
damaging. All alleles of SNPs (rs28706550, rs35203737, rs41429348, rs12906373, rs41435250, and rs13329473) were
monoallelic in this population. No allele frequency difference for rs8818 and rs3522 SNP between patients and controls
(p values were 0.126 and 0.994 respectively).
Conclusions: Similar to almost all non-African populations tested thus far, the “G” allele of both rs1048661 and rs3825942
SNPs were associated with the risk of PEG in the Saudi Arab population.
Pseudoexfoliation syndrome (XFS) is characterized by
deposits  of  grayish-white  material  seen  primarily  in  the
anterior segment of the eye. The deposits are primarily found
along the pupillary border and often produce a characteristic
pattern on the anterior lens surface [1]. XFS is frequently
associated with pseudoexfoliation glaucoma (PEG), which
often  has  a  more  aggressive  clinical  course  and  worse
prognosis  than  the  more  common  primary  open  angle
glaucoma (POAG) [2]. The incidence of PEG in XFS patients
varies  and  seems  highest  among  individuals  with
Scandinavian  and  Northern  European  ancestry  and  lower
among African Americans and in West Africa [3-5]. The
prevalence  of  PEG  in  Saudi  Arabia  is  unknown.  The
Glaucoma unit at King Abdulaziz University Hospital (where
most PEG patients were recruited for this study) sees around
600 new glaucoma patients every year, and about 10% of those
are PEG.
Thorleifsson and colleagues [6] have reported a genome-
wide association study that identified a strong association
between three single nucleotide polymorphisms (SNPs) in the
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lysyl  oxidase-like  1  (LOXL1)  gene.  They  identified  one
intronic SNP (rs2165241) and two non-synonyrnous coding
SNPs (rs1048661 and rs3825942) with significant disease
association in Icelandic and Swedish subjects. LOXL1 belongs
to  the  “LOX”  family  of  extracellular  enzymes  that  have
multiple functions including the cross-linking of collagen and
elastin by oxidatively deaminating lysine residues. Since XFS
deposits are associated with the extracellular and basement
membrane regions, the LOX genes are legitimate functional
candidates to be involved with PEG pathogenesis [7].
The  association  of  LOXL1  SNPs  (in  particular
rs1048661  and  rs3825942)  with  XFS/PEG  has  now  been
studied in Caucasian populations in the USA [8], Australia
[9], Austria [10], Germany [11], Italy [12], and Finland and
in other ethnic groups, including Japanese [13], Indian [14],
Chinese [15], and recently black South Africans [16]. The “G”
allele of SNP rs3825942 is significantly associated with XFS/
PEG in all populations tested to date [17] with the exception
of black South Africans where the “A” allele is the risk allele
[16].
The “G” allele of SNP rs1048661 is associated with XFS/
PEG in all populations except in the Indian [14] and Chinese
[15] populations. In other studies, the opposite “T” allele of
SNP rs1048661 was shown to be the risk allele for PEG in the
Chinese [18] and Japanese [19] populations.
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2805This study was conducted to examine the frequency of
various  polymorphisms  of  LOXL1  in  the  Saudi  Arabian
population with PEG and to evaluate whether SNPs in the
LOXL1  gene  associated  with  the  risk  of  PEG  in  this
population.
METHODS
Study  population:  The  study  adheres  to  the  tenets  of  the
Declaration  of  Helsinki,  and  all  participants  signed  an
informed consent. The study was approved by College of
Medicine ethical committee (proposal number # 08–657). All
study subjects were self identified as Saudi Arabian ethnicity.
Family names were all present in the database of Arab families
of Saudi Arabian origin. Additionally, these names indicated
that all five major Saudi Arabian provinces were represented
in the study population. Expatriates were excluded from this
study and all patients and controls were Saudi Arabs. Subjects
with  clinically  diagnosed  PEG  and  healthy  controls  were
recruited into the study at King Abdulaziz University Hospital
in  Riyadh,  Saudi  Arabia.  All  participants  underwent  a
standardized  detailed  ophthalmic  examination,  which
included  measurement  of  intraocular  pressure  (IOP)  by
Goldmann applanation tonometry, slit lamp biomicroscopy,
gonioscopy, and dilated examination of the lens and fundus.
Subjects  with  PEG  were  defined  as  those  with  clinical
evidence  of  exfoliation  material  on  the  pupil  margin  or
anterior lens surface and the presence of glaucomatous optic
neuropathy with associated visual field loss in one or both eyes
and documented IOP ≥22 mmHg in either eye. Saudi Arab
subjects  with  normal  anterior  segment  and  optic  nerve
examination,  IOP  <18  mmHg,  and  no  clinical  signs  of
exfoliation were recruited as control subjects.
DNA analysis: Five ml of peripheral blood were collected in
EDTA tubes from all participating individuals. DNA was
extracted using the illustra blood genomicPrep Mini Spin Kit
from GE Healthcare (Buckinhamshire, UK), and stored at
−20 °C in aliquots until required. PCR amplifications of the 7
exons and the promoter region of LOXL1 were performed
using the primers listed in Table 1. Successfully amplified
fragments were sequenced in both directions using the M13
forward and reverse primers and the BigDye terminator v3.1
cycle sequencing kit (Applied Biosystems, Foster city, CA).
Fragments were then run on the 3130xl Genetic Analyzer
(Applied Biosystems) according to the manufacturer protocol.
All  the  sequenced  fragments  were  then  analyzed  using
SeqScape  software  v2.6  (Applied  Biosystems).  Allele
frequencies  for  SNP  rs1048661  and  rs3825942  were
confirmed by repeating the sequencing in both the forward
and reverse directions. Table 1 details the sequence of the
primers  used,  the  PCR  annealing  temperature,  and  the
expected amplicon size.
Statistical analysis: Allele frequencies in study groups were
compared using the χ2 test. A two tailed p value <0.05 was
considered statistically significant. An exact test for Hardy–
Weinberg equilibrium (HWE) of the observed genotypes was
performed. Given the known high consanguinity rate in Saudi
Arabia (>65% in some areas; see Panter [20]) and the possible
absence  of  random  mating  in  this  population,  we  also
calculated allelic association p values that were adjusted for
deviation from HWE using the method described in Schaid
and Jacobsen [21]. All analyses were performed using SPSS
v.10 (SPSS Inc., Chicago, IL) and SAS v.9.1 (SAS Institute
Incl,  Cary,  NC)  statistical  analysis  software.  Common
TABLE 1. PRIMER SEQUENCES, PCR ANNEALING TEMPERATURE, AND AMPLICON SIZE FOR LOXL1.
Exon Primer sequence Annealing temperature (°C) Amplicon size
(bp)
Promoter-F TGTAAAACGACGGCCAGTAGGGACTGAGGGAGCACT 60 465
Promoter-R CAGGAAACAGCTATGACCAGCCATGGTGACCCCTCT    
1A-F TGTAAAACGACGGCCAGTTCCCAGCCTGTTGCTTATTC 60 789
1A-R CAGGAAACAGCTATGACCGTTGCTGGGAGACGGAGGT    
1B-F TGTAAAACGACGGCCAGTATTCGGCTTTGGCCAGGT 60 810
1B-R CAGGAAACAGCTATGACCCCGGAGCAGTTTCCAGTG    
1C-F• TGTAAAACGACGGCCAGTGCTCAACTCGGGCTCAGA 57 553
1C-R• CAGGAAACAGCTATGACCCGCCGTACTCCTCGTAGC    
2-F TGTAAAACGACGGCCAGTTGCTCTCAATGTCATGCTCTT 60 209
2-R CAGGAAACAGCTATGACCCGGGGACTATCCCAACACT    
3-F TGTAAAACGACGGCCAGTGTGTCACTGTGCCCCAACC 60 232
3-R CAGGAAACAGCTATGACCCCCAGAGGAGAAGTGGAAGA    
4-F TGTAAAACGACGGCCAGTGAGAGGCCCAGGGAAGACTA 58 265
4-R CAGGAAACAGCTATGACCCCTCCCCAACTCCTTATCCT    
5-F TGTAAAACGACGGCCAGTGGGGTGGCTCTGGGAAAC 58 210
5-R CAGGAAACAGCTATGACCGGGGGACATTGGACATGA    
6-F TGTAAAACGACGGCCAGTCCCCTGACTAGACTCCCTTTC 60 234
6-R CAGGAAACAGCTATGACCGTATCTCAGGTGGCCTTGC    
7-F TGTAAAACGACGGCCAGTCTACTTTGCAGCCCCTCATT 60 410
7-R CAGGAAACAGCTATGACCCCAGGCCCAAACTAGCTG    
        In the table, F: Forward; R: Reverse; •SNPs rs1048661 and rs3825942 were amplified with this primer set. Bold and underlined
        sequences are those of M13.
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correction for multiple testing.
RESULTS
Ninety three PEG patients and 101 controls were recruited into
this study. Of the 93 PEG patients there were 61 males and 32
females with a mean age of 72.3 (SD 12.02). Of the 101
controls there were 64 males and 37 females with a mean age
of  69.3  (SD  12.4).  The  full  coding  region,  exon-intron
boundaries,  the  promoter  region  (470  bases  before  the
transcriptional start site), and the 5′UTR and 3′UTR of the
LOXL1 gene was sequenced in all subjects.
The “G” allele frequencies of both rs1048661 (0.876) and
rs3825942 (0.968) SNPs differed significantly between PEG
patients  and  controls  subjects  (p=0.0056  and  0.000005,
respectively).  If  we  consider  the  4  common  SNPs
(rs1048661, rs3825942, rs28706550, and rs35203737), then
the  Bonferroni  corrected  p-value  should  be  0.0125.  After
applying  the  Bonferroni  correction,  SNPs  rs1048661  and
rs3825942 remained significant.
There  was  no  statistically  significant  difference  in
genotype frequencies between patients and controls for SNP
rs1048661 (p values were 0.409 and 1.000 for genotypes G/
G and G/T respectively). As for SNP rs3825942, there was a
statistically  significant  difference  between  patients  and
controls for the G/G genotype (p=0.049), but that significance
disappeared after applying Bonferroni correction. As for the
G/A genotype of SNP rs3825942, there was no difference in
genotype frequency between patients and controls (p=1.000).
Genotypes  of  SNPs  rs28706550  and  rs35203737  were
monogeneic in all patients and controls (Table 2).
Alleles of SNPs rs28706550, rs35203737, rs41429348,
rs12906373, rs41435250, and rs13329473 were monoallelic
in all PEG subjects and controls.
There was no significant difference in allele frequencies
between cases and controls for the rs8818 and rs3522 SNPs
(p values were 0.126 and 0.994, respectively; Table 3).
Genotypes at SNPs rs1048661, rs3825942, rs8818, and
rs3522 were in HWE for both patients and controls (p≥0.05).
Since the test for deviation from HWE has limited statistical
TABLE 2. GENOTYPE FREQUENCIES OF THE FOUR MOST COMMON LOXL1 SNPS.
SNP I.D Nucleotide change Genotype XFG patients (n=93) Controls (n=101) p value
rs1048661 g.5758 G>T G/G 72 (77.4%) 57 (56.4%) 0.409
    G/T 19 (20.4%) 40 (39.6%) 1.000
    T/T 2 (2.2%) 4 (4%) reference
rs3825942 g.5794 G>A G/G 88 (94.6%) 70 (69.3%) 0.049
    G/A 4 (4.3%) 25 (24.7%) 1.000
    A/A 1 (1.1%) 6 (6%) reference
rs28706550 g.25067 A>C A/A 93 (100%) 101 (100%) -
    A/C 0 (0) 0 (0) -
    C/C 0 (0) 0 (0) reference
rs35203737 g.28103 C>A C/C 93 (100%) 101 (100%) -
    C/A 0 (0) 0 (0) -
    A/A 0 (0) 0 (0) reference
TABLE 3. ALLELE FREQUENCIES OF VARIOUS LOXL1-SNPS IN PEG PATIENTS AND CONTROLS.
SNP I.D. Nucleotide change Amino acid change Allele PEG patients (n=93) Controls (n=101) p value
rs1048661 g.5758 G>T R141L G 163 (0.876)• 154 (0.762) 0.0056
rs3825942 g.5794 G>A G153D G 180 (0.968) 165 (0.817) 0.000005
rs28706550 g.25067 A>C N437H A 186 (1) 202 (1) N/A
rs35203737 g.28103 C>A S565Y C 186 (1) 202 (1) N/A
Novel g.25722 C>G D484E C 184 (0.99) 202 (1) N/A
Novel g.28084 T>G Y559D T 185 (0.995) 202 (1) N/A
rs8818 g.30490 C>G - G 141 (0.758) 138 (0.683) 0.126
rs3522 g.30556 C>T - C 116 (0.624) 125 (0.619) 0.994
rs41429348 g.6212 C>T - C 186 (1) 202 (1) N/A
rs12906373 g.6272 C>T - C 186 (1) 202 (1) N/A
rs41435250 g.6296 G>T - G 186 (1) 202 (1) N/A
rs13329473 g.25737 C>T - C 186 (1) 202 (1) N/A
         LOXL1 indicates lysyl oxidase-like 1; PEG indicates exfoliation glaucoma. Alleles in bold were considered the risk alleles in
         calculating p value. Nucleotide are numbered as in GenBank accession number NG_011466 .. •Numbers in parenthesis represent
         the allele frequency. Novel indicates not previously reported. N/A indicates not applicable.
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mating  may  exist  in  the  study  population  [20],  we  also
calculated allelic association p-values that are adjusted for
deviation from HWE. The results (p=0.00257 for rs1048661
and p=0.00000479 for rs3825942) indicated that the presence
of allelic association was robust to the absence or presence of
HWE.
We  detected  two  previously  unreported  SNPs  in  this
population. The rare allele was found in PEG subjects but not
the controls for both SNPs. The first SNP is g.25722 C>G in
exon 4 of the LOXL1 gene and results in a replacement of
aspartic acid with glutamic acid at codon 484 (D484E). This
SNP was detected in 2/93 (2.15%) of PEG patients and was
predicted by PolyPhen to be benign with no pathological
consequences on the protein structure and/or function (Table
4). The second novel SNP g.28084 T>G was detected in exon
6 of the LOXL1 gene and resulted in a replacement of tyrosine
with  aspartic  acid  at  codon  559  (Y559D).  This  SNP  was
detected in one PEG patient (1.1%), but not in the controls.
Polyphen predicted this SNP to be probably damaging (Table
4) and thus may affect the protein structure and/or function.
DISCUSSION
To our knowledge, this is the first study to evaluate whether
SNPs in LOXL1 associated with the risk of PEG in the Saudi
Arab population. We first evaluated the prevalence of non-
synonymous SNPs in LOXL1 in PEG patients and glaucoma-
free controls and compared the results in both groups. The
results, presented in Table 3, indicate that the prevalence of
the “G” allele of SNP rs1048661 in PEG patients (0.876) was
higher than the controls (0.762) and that this difference was
statistically significant (p=0.0056). After applying Bonferroni
correction,  the  genotype  frequencies  were  comparable  in
patients and controls and the difference was not statistically
significant (Table 2). This indicates that the allele and not the
genotype may contribute or act as a risk for the disease. The
“G” allele frequency of 0.876 observed in Saudi Arabian PEG
patients was comparable to the rate observed in Icelandic
(0.781),  Swedish  (0.834),  Americans  (0.819),  Austrians
(0.841), Germans (0.818), Italians (0.825), Finnish (0.825),
and South Africans (0.990) [17]. However, it was higher than
the rate observed in Chinese (0.110) and Japanese (0.036)
populations [17]. This indicates that the variability of the “G”
allele  frequencies  depends  on  region  and  ethnicity.  The
significant association of the “G” allele of SNP rs1048661
with  PEG  in  the  Saudi  Arab  population  mirrors  the  rate
observed in the Icelandic, Swedish, American, Australian,
Austrian,  German,  Italian,  Finnish,  Japanese,  and  South
African  populations  and  differ  from  that  observed  in  the
Indian [14] and Chinese [15] populations (Table 5). In other
studies, the opposite “T” allele of SNP rs1048661 was shown
to be the risk allele for PEG in the Chinese [18] and Japanese
[19] populations and thus raising doubts about the pathogenic
role of SNP rs1048661.
This study confirms a significant association between the
“G”  allele  of  SNP  rs3825942  in  cases  versus  controls
(p=0.000005). Despite our in silico analysis using PolyPhen
which predicted that this SNP was possibly damaging and that
the amino acid glycine was highly conserved at codon 153 in
many species, some doubts about the pathological role of this
SNP in PEG were raised. This stems from previous reports
that this SNP does not appear to affect LOXL1 gene expression
levels  in  blood  or  ocular  tissues  [6,22].  Additionally,  the
recent study in a South African population [16], where the “G”
allele of SNP rs3825942 was protective and the opposite allele
“A” was the risk allele for PEG, raises further uncertainties
about the pathological role of this SNP.
Sequencing  the  coding  region  of  the  LOXL1  gene
revealed two previously unreported SNPs (g.25722 C>G and
g.28084 T>G) detected in PEG patients and not in the controls.
In silico analysis using PolyPhen predicted that g.25722 C>G
is benign and that g.28084 T>G was probably damaging. We
cannot be certain what role these two non- synonymous SNPs
play in the development of PEG, although it is possible that
either  one  of  these  two  SNPs  can  be  used  for  PEG  risk
assessment.
In summary we showed that the “G” allele of LOXL1
SNPs rs1048661 and rs3825942 are associated with PEG in
TABLE 4. ANALYSIS OF NON-SYNONYMOUS SEQUENCE CHANGES IN THE LOXL1 GENE DETECTED IN THE STUDY GROUP.
SNP ID Nucleotide sequence change Amino acid change Location Interspecies
conservation
PolyPhen prediction
rs1048661 g.5758 G>T R141L Exon 1 High Probably damaging
rs3825942 g.5794 G>A G153D Exon 1 High Possibly damaging
Novel g.25722 C>G D484E Exon 4 High Benign
Novel g.28084 T>G Y559D Exon 6 High Probably damaging
        Non-synonymous indicates sequence change which results in an amino acid change. PolyPhen=Polymorphism Phenotyping is
        a tool which predicts possible impact of an amino acid substitution on the structure and function of a human protein using
        straightforward physical and comparative considerations. “Probably damaging” constitutes high confidence of affecting protein
        function. “Possibly damaging” reflects a likelihood of affecting protein function or structure, while “Benign” changes most
        likely lack phenotypic effect.
Molecular Vision 2010; 16:2805-2810 <http://www.molvis.org/molvis/v16/a300> © 2010 Molecular Vision
2808the Saudi populations in a fashion similar to other non-African
populations.
ACKNOWLEDGMENTS
The  authors  thank  the  Glaucoma  Research  Chair  at  the
Department of Ophthalmology, College of Medicine, King
Saud University for funding of this study.
REFERENCES
1. Schlotzer-Schrehardt U, Kuchle M, Naumann GO. Electron-
microscopic identification of pseudoexfoliation material in
extrabulbar  tissue.  Arch  Ophthalmol  1991;  109:565-70.
[PMID: 2012560]
2. Ritch  R.  Exfoliation  syndrome:  beyond  glaucoma.  Arch
Ophthalmol 2008; 126:859-61. [PMID: 18541854]
3. Ball  SF.  Exfoliation  syndrome  prevalence  in  the  glaucoma
population of South Louisiana. Acta Ophthalmol Suppl 1988;
184:93-8. [PMID: 2853928]
4. Cashwell LF Jr, Shields MB. Exfoliation syndrome. Prevalence
in a southeastern United States population. Arch Ophthalmol
1988; 106:335-6. [PMID: 3345150]
5. Herndon LW, Challa P, Ababio-Danso B, Boateng JO, Broomer
B, Ridenhour P, Allingham RR. Survey of glaucoma in an eye
clinic in Ghana, West Africa. J Glaucoma 2002; 11:421-5.
[PMID: 12362082]
6. Thorleifsson  G,  Magnusson  KP,  Sulem  P,  Walters  GB,
Gudbjartsson DF, Stefansson H, Jonsson T, Jonasdottir A,
Stefansdottir  G,  Masson  G,  Hardarson  GA,  Petursson  H,
Arnarsson A, Motallebipour M, Wallerman O, Wadelius C,
Gulcher  JR,  Thorsteinsdottir  U,  Kong  A,  Jonasson  F,
Stefansson K. Common sequence variants in the LOXL1 gene
confer susceptibility to exfoliation glaucoma. Science 2007;
317:1397-400. [PMID: 17690259]
7. Ovodenko B, Rostagno A, Neubert TA, Shetty V, Thomas S,
Yang A, Liebmann J, Ghiso J, Ritch R. Proteomic analysis of
exfoliation  deposits.  Invest  Ophthalmol  Vis  Sci  2007;
48:1447-57. [PMID: 17389470]
8. Fingert  JH,  Alward  WL,  Kwon  YH,  Wang  K,  Streb  LM,
Sheffield VC, Stone EM. LOXL1 mutations are associated
with exfoliation syndrome in patients from the midwestern
United States. Am J Ophthalmol 2007; 144:974-5. [PMID:
18036875]
9. Hewitt AW, Sharma S, Burdon KP, Wang JJ, Baird PN, Dimasi
DP, Mackey DA, Mitchell P, Craig JE. Ancestral LOXL1
variants are associated with pseudoexfoliation in Caucasian
Australians  but  with  markedly  lower  penetrance  than  in
Nordic  people.  Hum  Mol  Genet  2008;  17:710-6.  [PMID:
18037624]
10. Mossbock G, Renner W, Faschinger C, Schmut O, Wedrich A,
Weger  M.  Lysyl  oxidase-like  protein  1  (LOXL1)  gene
polymorphisms  and  exfoliation  glaucoma  in  a  Central
European  population.  Mol  Vis  2008;  14:857-61.  [PMID:
18483563]
11. Wolf C, Gramer E, Muller-Myhsok B, Pasutto F, Gramer G,
Wissinger  B,  Weisschuh  N.  Lysyl  oxidase-like  1  gene
polymorphisms  in  German  patients  with  normal  tension
glaucoma, pigmentary glaucoma and exfoliation glaucoma. J
Glaucoma 2010; 19:136-41. [PMID: 19373106]
12. Pasutto F, Krumbiegel M, Mardin CY, Paoli D, Lammer R,
Weber  BH,  Kruse  FE,  Schlotzer-Schrehardt  U,  Reis  A.
Association of LOXL1 common sequence variants in German
and  Italian  patients  with  pseudoexfoliation  syndrome  and
pseudoexfoliation  glaucoma.  Invest  Ophthalmol  Vis  Sci
2008; 49:1459-63. [PMID: 18385063]
13. Hayashi H, Gotoh N, Ueda Y, Nakanishi H, Yoshimura N.
Lysyl  oxidase-like  1  polymorphisms  and  exfoliation
syndrome in the Japanese population. Am J Ophthalmol 2008;
145:582-5. [PMID: 18201684]
14. Ramprasad VL, George R, Soumittra N, Sharmila F, Vijaya L,
Kumaramanickavel  G.  Association  of  non-synonymous
single nucleotide polymorphisms in the LOXL1 gene with
TABLE 5. SUMMARY OF THE GENETICS ASSOCIATION OF THE TWO CODING SNPS IN THE LOXL1 GENE AS REPORTED IN VARIOUS POPULATIONS.
  rs1048661“G” Allele rs3825942 “G” allele  





American 0.819 0.600 0.000036 0.986 0.880 0.0003 [8]
American 0.787 0.665 0.0222 0.939 0.844 0.0194 [24]
American 0.843 0.703 7.74×10−19 0.959 0.798 3.10×10−17 [25]
American 0.829 0.719 0.0031 0.988 0.795 1.3×10−13 [26]
Australian 0.780 0.660 8.49×10−4 0.950 0.840 7.83×10−5 [9]
Austrian 0.841 0.671 <0.001 0.994 0.817 <0.001 [10]
Chinese 0.542 0.444 0.142 0.992 0.918 0.0018 [15]
Finnish 0.825 0.683 2.65×10−5 0.968 0.823 2.24×10−8 [27]
Germany 0.818 0.644 3.16×10−8 0.951 0.857 6.5×10−13 [11]
Iceland 0.781 0.651 1.8×10−6 0.984 0.847 4.1×10−9 [6]
Indian 0.721 0.634 0.156 0.923 0.742 0.0001 [14]
Italian 0.825 0.693 2.90×10−19 1.000 0.821 1.28×10−40 [12]
Japanese 0.005 0.554 >0.05 0.993 0.806 1.7×10−8 [19]
South African 0.990 0.810 1.7×10−5 0.130 0.620 5.2×10-13• [23]
Swedish 0.834 0.682 2.7×10−7 0.995 0.879 9.1×10−14 [6]
Saudi Arabian 0.876 0.762 0.0056 0.968 0.817 0.000005 This study
         •The p value reported here is in favor of the controls as the G allele was more frequent in controls (0.620) than in patients (0.130).
         In the South African population, the opposite allele “A” was the risk allele [23].
Molecular Vision 2010; 16:2805-2810 <http://www.molvis.org/molvis/v16/a300> © 2010 Molecular Vision
2809pseudoexfoliation  syndrome  in  India.  Mol  Vis  2008;
14:318-22. [PMID: 18334947]
15. Lee  KY,  Ho  SL,  Thalamuthu  A,  Venkatraman  A,
Venkataraman D, Pek DC, Aung T, Vithana EN. Association
of  LOXL1  polymorphisms  with  pseudoexfoliation  in  the
Chinese. Mol Vis 2009; 15:1120-6. [PMID: 19503743]
16. Williams SE, Whigham BT, Liu Y, Carmichael TR, Qin X,
Schmidt S, Ramsay M, Hauser MA, Allingham RR. Major
LOXL1 risk allele is reversed in exfoliation glaucoma in a
black South African population. Mol Vis 2010; 16:705-12.
[PMID: 20431720]
17. Chen H, Chen LJ, Zhang M, Gong W, Tam PO, Lam DS, Pang
CP.  Ethnicity-based  subgroup  meta-analysis  of  the
association of LOXL1 polymorphisms with glaucoma. Mol
Vis 2010; 16:167-77. [PMID: 20142848]
18. Chen L, Jia L, Wang N, Tang G, Zhang C, Fan S, Liu W, Meng
H, Zeng W, Liu N, Wang H, Jia H. Evaluation of LOXL1
polymorphisms  in  exfoliation  syndrome  in  a  Chinese
population. Mol Vis 2009; 15:2349-57. [PMID: 19936304]
19. Tanito M, Minami M, Akahori M, Kaidzu S, Takai Y, Ohira A,
Iwata T. LOXL1 variants in elderly Japanese patients with
exfoliation  syndrome/glaucoma,  primary  open-angle
glaucoma, normal tension glaucoma, and cataract. Mol Vis
2008; 14:1898-905. [PMID: 18958304]
20. Panter-Brick C. Parental responses to consanguinity and genetic
disease in Saudi Arabia. Soc Sci Med 1991; 33:1295-302.
[PMID: 1776043]
21. Schaid  DJ,  Jacobsen  SJ.  Biased  tests  of  association:
comparisons  of  allele  frequencies  when  departing  from
Hardy-Weinberg  proportions.  Am  J  Epidemiol  1999;
149:706-11. [PMID: 10206619]
22. Schlotzer-Schrehardt  U,  Pasutto  F,  Sommer  P,  Hornstra  I,
Kruse  FE,  Naumann  GO,  Reis  A,  Zenkel  M.  Genotype-
correlated expression of lysyl oxidase-like 1 in ocular tissues
of patients with pseudoexfoliation syndrome/glaucoma and
normal patients. Am J Pathol 2008; 173:1724-35. [PMID:
18974306]
23. Williams SE, Whigham BT, Liu Y, Carmichael TR, Qin X,
Schmidt S, Ramsay M, Hauser MA, Allingham RR. Major
LOXL1 risk allele is reversed in exfoliation glaucoma in a
black South African population. Mol Vis 2010; 16:705-12.
[PMID: 20431720]
24. Challa P, Schmidt S, Liu Y, Qin X, Vann RR, Gonzalez P,
Allingham  RR,  Hauser  MA.  Analysis  of  LOXL1
polymorphisms  in  a  United  States  population  with
pseudoexfoliation  glaucoma.  Mol  Vis  2008;  14:146-9.
[PMID: 18334928]
25. Aragon-Martin JA, Ritch R, Liebmann J, O'Brien C, Blaaow K,
Mercieca F, Spiteri A, Cobb CJ, Damji KF, Tarkkanen A,
Rezaie T, Child AH, Sarfarazi M. Evaluation of LOXL1 gene
polymorphisms  in  exfoliation  syndrome  and  exfoliation
glaucoma. Mol Vis 2008; 14:533-41. [PMID: 18385788]
26. Fan  BJ,  Pasquale  L,  Grosskreutz  CL,  Rhee  D,  Chen  T,
DeAngelis MM, Kim I, del Bono E, Miller JW, Li T, Haines
JL, Wiggs JL. DNA sequence variants in the LOXL1 gene are
associated with pseudoexfoliation glaucoma in a U.S. clinic-
based  population  with  broad  ethnic  diversity.  BMC  Med
Genet 2008; 9:5. [PMID: 18254956]
27. Lemmela S, Forsman E, Onkamo P, Nurmi H, Laivuori H,
Kivela T, Puska P, Heger M, Eriksson A, Forsius H, Jarvela
I.  Association  of  LOXL1  gene  with  Finnish  exfoliation
syndrome patients. J Hum Genet 2009; 54:289-97. [PMID:
19343041]
Molecular Vision 2010; 16:2805-2810 <http://www.molvis.org/molvis/v16/a300> © 2010 Molecular Vision
The print version of this article was created on 13 December 2010. This reflects all typographical corrections and errata to the
article through that date. Details of any changes may be found in the online version of the article.
2810